Literature DB >> 8599878

The thymus and the pathogenesis of myasthenia gravis.

A I Levinson1, L M Wheatley.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8599878     DOI： 10.1006/clin.1996.0001

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  10 in total

Review 1.  Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.

Authors:  Arnold I Levinson; Yi Zheng; Glen Gaulton; Decheng Song; Jonni Moore; C Hank Pletcher
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma).

Authors:  Y Kadota; M Okumura; S Miyoshi; S Kitagawa-Sakakida; M Inoue; H Shiono; Y Maeda; T Kinoshita; R Shirakura; H Matsuda
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 3.  Spontaneous germinal centers and autoimmunity.

Authors:  Phillip P Domeier; Stephanie L Schell; Ziaur S M Rahman
Journal:  Autoimmunity       Date:  2017-02       Impact factor: 2.815

Review 4.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

5.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis.

Authors:  Amel Meraouna; Geraldine Cizeron-Clairac; Rozen Le Panse; Jacky Bismuth; Frederique Truffault; Chantal Tallaksen; Sonia Berrih-Aknin
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

Review 6.  Biological implications of thymectomy for myasthenia gravis.

Authors:  Meinoshin Okumura; Masayoshi Inoue; Yoshihisa Kadota; Akio Hayashi; Toshiteru Tokunaga; Takashi Kusu; Noriyoshi Sawabata; Hiroyuki Shiono
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

7.  The Expression Pattern and Regulatory Mechanism of the G0/G1 Switch Gene 2 (G0S2) in the Pathogenesis and Treatment of AChR Myasthenia Gravis (MG).

Authors:  Liqun Xu; Zhibin Li; Yi Li; Zhaohui Luo; Yuebei Luo; Bo Xiao; Huan Yang
Journal:  Mediators Inflamm       Date:  2020-09-30       Impact factor: 4.711

8.  Two polymorphic mutations in promoter region of DNA polymerase β in relatively higher percentage of thymic hyperplasia patients.

Authors:  Qingjun Wu; Shan Zhou; Jian Liu; Hongfeng Tong; Yaoguang Sun; Wenxin Tian; Hanbo Yu; Chuan Huang; Donghang Li; Peng Jiao; Chao Ma; Jianping Cai; Dapeng Dai
Journal:  Thorac Cancer       Date:  2020-12-13       Impact factor: 3.500

Review 9.  New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Authors:  Anthony Behin; Rozen Le Panse
Journal:  J Neuromuscul Dis       Date:  2018

Review 10.  Germinal Centre Shutdown.

Authors:  Theinmozhi Arulraj; Sebastian C Binder; Philippe A Robert; Michael Meyer-Hermann
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.